BCL2 and cancer: The BCL‐2 family, with its pro‐ and antiapoptotic constituents, is implicated in the delicate balance of cell survival signaling, often perturbed in cancers through the overexpression of antiapoptotic proteins, fostering a survival bias and impeding therapeutic efficacy.